Eli Lilly Free Cash Flow 2010-2024 | LLY

Eli Lilly free cash flow for the twelve months ending December 31, 2024 was , a year-over-year.

  • Eli Lilly annual free cash flow for 2024 was $3.76B, a 374.46% increase from 2023.
  • Eli Lilly annual free cash flow for 2023 was $0.793B, a 86.17% decline from 2022.
  • Eli Lilly annual free cash flow for 2022 was $5.731B, a 5.36% decline from 2021.

Eli Lilly Free Cash Flow 2010-2024 | LLY

  • Eli Lilly annual free cash flow for 2024 was $3.76B, a 374.46% increase from 2023.
  • Eli Lilly annual free cash flow for 2023 was $0.793B, a 86.17% decline from 2022.
  • Eli Lilly annual free cash flow for 2022 was $5.731B, a 5.36% decline from 2021.
Related Stocks
Company NameMarket
Cap
Johnson & Johnson (JNJ)$380.1B
Novo Nordisk (NVO)$374.3B
AbbVie (ABBV)$348.4B
Roche Holding AG (RHHBY)$259.5B
Novartis AG (NVS)$218.5B
Merck (MRK)$216.5B
Pfizer (PFE)$146.7B
Sanofi (SNY)$136B
Bayer (BAYRY)$22B
Innoviva (INVA)$1.1B